Is this really the end of beta-blockers in patients with cirrhosis and refractory ascites?

Hepatology. 2011 Feb;53(2):715-6. doi: 10.1002/hep.23839. Epub 2010 Jul 29.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adrenergic beta-Antagonists* / therapeutic use
  • Ascites / drug therapy*
  • Ascites / mortality
  • Contraindications
  • Humans
  • Hypertension, Portal / mortality
  • Hypertension, Portal / physiopathology
  • Liver Cirrhosis / drug therapy*
  • Liver Cirrhosis / mortality
  • Propranolol / therapeutic use
  • Survival Rate
  • Treatment Outcome

Substances

  • Adrenergic beta-Antagonists
  • Propranolol